NitinOhriMD

Radiation Oncology • New York, NY

Assistant Professor, Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine

Join to view full profile

Dr. Ohri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ohri's full profile

Already have an account?

Office
225 E 126th St
New York, NY 10035
Phone+1 646-968-9064

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2008 - 2012
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2007 - 2008
Washington University in St. Louis School of MedicineClass of 2007

Certifications & Licensure

NY State Medical License 2012 - 2025
PA State Medical License 2008 - 2012
American Board of Radiology Radiation Oncology

Clinical Trials

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer Start of enrollment: 2013 Jul 01
Completed
Phase 2
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer Start of enrollment: 2015 Jun 01
Completed
Real-time Activity Monitoring to Prevent Admissions During RadioTherapy Start of enrollment: 2016 Jul 01
Completed
Not Applicable
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery Start of enrollment: 2017 Feb 16
Completed
Not Applicable
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial. Start of enrollment: 2018 Aug 30
Active, not recruiting
Phase 2
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma Start of enrollment: 2022 Jul 25
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Untapping the Prognostic Value of Patient-Generated Health Data in Locally Advanced Non-small Cell Lung Cancer.
Nitin Ohri, William Bodner, Madhur Garg, Brendon Stiles, Balazs Halmos
Clinical Lung Cancer. 2024-12-01
Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis.
Daniel S Alicea, Emily Miao, Peter Ch'en, Steven W Tuckman, Nitin Ohri
Journal of the American Academy of Dermatology. 2024-11-14
3 citations
Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges.
Angelica D'Aiello, Brendon Stiles, Nitin Ohri, Benjamin Levy, Perry Cohen
Clinical Lung Cancer. 2024-05-01

Journal Articles

Radiation Therapy for Patients with Newly Diagnosed Metastatic Head and Neck Squamous Cell Carcinoma
Rafi Kabarriti, Nitin Ohri, Chandan Guha, Madhur K Garg, Sujith Baliga, Shalom Kalnicki, Head & Neck

Lectures

The selective personalized radioimmunotherapy for locally advanced NSCLC trial (SPRINT).
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

AI Model Predicts the Likelihood of Unplanned Hospitalization During Radiation Treatments for CancerOctober 24th, 2022
Patient Step Counts Predict Lung Cancer Treatment Outcomes, Study FindsJanuary 8th, 2020
Koneksa Health Announces Poster Presentation at ASCO Quality Care SymposiumSeptember 6th, 2019
Join now to see all